Im Cannabis Net Worth
Im Cannabis Net Worth Breakdown | IMCC |
Im Cannabis Net Worth Analysis
Im Cannabis' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Im Cannabis' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Im Cannabis' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Im Cannabis' net worth analysis. One common approach is to calculate Im Cannabis' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Im Cannabis' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Im Cannabis' net worth. This approach calculates the present value of Im Cannabis' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Im Cannabis' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Im Cannabis' net worth. This involves comparing Im Cannabis' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Im Cannabis' net worth relative to its peers.
To determine if Im Cannabis is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Im Cannabis' net worth research are outlined below:
| Im Cannabis Corp generated a negative expected return over the last 90 days | |
| Im Cannabis Corp may become a speculative penny stock | |
| Im Cannabis Corp has high historical volatility and very poor performance | |
| Im Cannabis Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 48.8 M. Net Loss for the year was (10.23 M) with profit before overhead, payroll, taxes, and interest of 6.61 M. | |
| Im Cannabis Corp currently holds about 5.86 M in cash with (8.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 44.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Financial Analysis IM Cannabis Hero Technologies |
Im Cannabis Quarterly Good Will |
|
Know Im Cannabis' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Im Cannabis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Im Cannabis Corp backward and forwards among themselves. Im Cannabis' institutional investor refers to the entity that pools money to purchase Im Cannabis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 0.0 | Advisorshares Investments, Llc | 2024-12-31 | 104.1 K | Bank Of Montreal | 2024-12-31 | 12.6 K | Bmo Capital Markets Corp. | 2024-12-31 | 12.6 K | Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 3.8 K | Royal Bank Of Canada | 2024-12-31 | 290 | Bryn Mawr Trust Company | 2024-12-31 | 9.0 | Sbi Securities Co Ltd | 2024-12-31 | 8.0 | Td Waterhouse Canada Inc | 2024-12-31 | 3.0 | Group One Trading, Lp | 2024-12-31 | 2.0 |
Follow Im Cannabis' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.4 M.Market Cap |
|
Project Im Cannabis' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.33) | (0.35) | |
| Return On Capital Employed | (0.87) | (0.92) | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | (0.75) | (0.79) |
When accessing Im Cannabis' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Im Cannabis' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Im Cannabis' profitability and make more informed investment decisions.
Please note, the presentation of Im Cannabis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Im Cannabis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Im Cannabis' management manipulating its earnings.
Evaluate Im Cannabis' management efficiency
Im Cannabis Corp has return on total asset (ROA) of (0.1531) % which means that it has lost $0.1531 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.173) %, meaning that it created substantial loss on money invested by shareholders. Im Cannabis' management efficiency ratios could be used to measure how well Im Cannabis manages its routine affairs as well as how well it operates its assets and liabilities. As of March 19, 2025, Return On Tangible Assets is expected to decline to -0.35. In addition to that, Return On Capital Employed is expected to decline to -0.92. At present, Im Cannabis' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 29.3 M, whereas Non Current Assets Total are forecasted to decline to about 17 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.23 | 1.17 | |
| Tangible Book Value Per Share | (0.20) | (0.19) | |
| Enterprise Value Over EBITDA | (19.52) | (20.49) | |
| Price Book Value Ratio | 2.81 | 2.67 | |
| Enterprise Value Multiple | (19.52) | (20.49) | |
| Price Fair Value | 2.81 | 2.67 | |
| Enterprise Value | 223.3 M | 198.5 M |
Im Cannabis showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 0.4167 | Revenue | Quarterly Revenue Growth 0.122 | Revenue Per Share | Return On Equity |
Im Cannabis Earnings per Share Projection vs Actual
Im Cannabis Corporate Management
| Shai Shemesh | Chief Officer | Profile | |
| Advocate Nissimov | General Counsel | Profile | |
| Michael Ruscetta | Chief Corp | Profile | |
| Richard Balla | Chief Adjupharm | Profile | |
| Rinat Efrima | Chief Israel | Profile | |
| Howard CFA | Chief MYM | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.02) | Revenue Per Share | Quarterly Revenue Growth 0.122 | Return On Assets | Return On Equity |
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.